The drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030, predicts Roots Analysis
Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.”

Drug repurposing enables drug developers to optimize onpast efforts and expenditure, thereby, offering a viable life cycle managementstrategy for marketed products and opportunities to re-evaluate failed /shelved drug development programs


Roots Analysis is pleased toannounce the publication of its recent study, titled, “DrugRepurposing Service ProvidersMarket, 2020-2030.


The report features an extensive study of the currentmarket landscape and future opportunities for players offering services forrepurposing / repositioning / reprofiling of drug candidates. It features anin-depth analysis, highlighting the capabilities of various service providersengaged in this domain. In addition to other elements, the study includes:

§  Adetailed assessment of the current market landscape of companies offering drugrepurposing services. 

§  Elaborateprofiles of key players that specialize in offering services for thedevelopment of repurposed drugs.

§  Ananalysis of the partnerships that have been established in this domain, in therecent past.

§  Ananalysis of the initiatives of big biopharma players engaged in this domain.

§  A detailedanalysis of more than 1,700 terminated / withdrawn / suspended clinical studiesof the drug candidates.

§  A detailedanalysis on the cost saving potential of drug repurposing approaches, ascompared to the traditional de novo drug development methods.

§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)

  • Type of Repurposing Approaches

§  Disease-centricapproach

§  Target-centricapproach

§  Drug-centricapproach

  • Therapeutic Area

§  SameTherapeutic Area

§  DifferentTherapeutic Area

  • Type of Drug Molecule

§  Biologics 

§  SmallMolecule

  • Key Geographical Region 

§  NorthAmerica

§  Europe

§  Asia-Pacific


Keycompanies covered in the report

§  Auxillis Pharma

§  ChemBio Discovery Solutions

§  Excelra

§  GVK Bio

§  Iris Pharma

§  Lantern Pharma

§  PanXome

§  Pharmacelera

§  Physiogenex

§  Smart Pharma

§  Socium

§  SOM Biotech


Formore information please click on the following link:


Other Recent Offerings

1.     Peptides and Macrocycle DrugDiscovery: Services and PlatformsMarket, 2020 - 2030

2.     China BiopharmaceuticalContractManufacturing Market, 2020-2030

3.     Antibody ContractManufacturingMarket, 2020 - 2030


About Roots Analysis

Roots Analysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at


Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415